Jennison Associates’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.3M | Hold |
|
|||||
|
2020
Q4 | $3.37M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $3.72M | Sell |
|
|||||
|
2020
Q1 | $32.3M | Sell |
|
|||||
|
2019
Q4 | $201M | Sell |
|
|||||
|
2019
Q3 | $200M | Sell |
|
|||||
|
2019
Q2 | $1.18B | Sell |
|
|||||
|
2019
Q1 | $1.38B | Buy |
|
|||||
|
2018
Q4 | $850M | Buy |
|
|||||
|
2018
Q3 | $1.2B | Buy |
|
|||||
|
2018
Q2 | $748M | Sell |
|
|||||
|
2018
Q1 | $835M | Buy |
|
|||||
|
2017
Q4 | $600M | Sell |
|
|||||
|
2017
Q3 | $748M | Buy |
|
|||||
|
2017
Q2 | $79.1M | Sell |
|
|||||
|
2017
Q1 | $1.17B | Buy |
|
|||||
|
2016
Q4 | $1.01B | Buy |
|
|||||
|
2016
Q3 | $875M | Buy |
|
|||||
|
2016
Q2 | $828M | Sell |
|
|||||
|
2016
Q1 | $1.02B | Sell |
|
|||||
|
2015
Q4 | $1.4B | Buy |
|
|||||
|
2015
Q3 | $1.07B | Buy |
|
|||||
|
2015
Q2 | $1.08B | Buy |
|
|||||
|
2015
Q1 | $908M | Sell |
|
|||||
|
2014
Q4 | $1.07B | Sell |
|
|||||
|
2014
Q3 | $1.39B | Buy |
|
|||||
|
2014
Q2 | $1.27B | Sell |
|
|||||
|
2014
Q1 | $1.28B | Sell |
|
|||||
|
2013
Q4 | $1.12B | Sell |
|
|||||
|
2013
Q3 | $1B | Sell |
|
|||||
|
2013
Q2 | $891M | Buy |
|